Stocks
Definium Therapeutics Prices $700M Public Offering
Definium Therapeutics announced the pricing of an upsized public offering, raising approximately $700 million in gross proceeds.
#stock offering 3 articles
Stocks
NervGen Pharma Prices $60 Million Public Offering
NervGen Pharma Corp. has priced a public offering of common shares and warrants, raising $60 million to advance its neuroreparative therapeutics.
Investing
Liberty Defense Prices U.S. IPO at $4.50 Per Share
Liberty Defense Holdings Ltd. has priced its U.S. initial public offering, selling 3,673,638 common shares at $4.50 each. The offering is expected...